Login / Signup

Ixekizumab, with or without concomitant methotrexate, improves signs and symptoms of PsA: week 52 results from Spirit-P1 and Spirit-P2 studies.

Bernard G CombeTsen-Fang TsaiJ Eugene HuffstutterAubrey Trevelin SpraberyChen-Yen LinSo Young ParkAndris KronbergsMatthew M HuffordPeter Nash
Published in: Arthritis research & therapy (2021)
ClinicalTrials.gov NCT01695239 and NCT02349295 .
Keyphrases
  • prostate cancer
  • high dose
  • case control
  • radical prostatectomy
  • clinical trial
  • placebo controlled
  • physical activity